Maxim Group analyst Naz Rahman downgrades Palisade Bio (NASDAQ:PALI) from Buy to Hold.
Why 5 Target Analysts Are Maintaining Ratings Following Q4 Results
Shares of Target Corporation (NYSE: TGT) declined sharply in early trading on Wednesday, despite the company reporting an earnings beat for its fourth quarter.